輸入代號或公司名稱後按 Enter
6574

霈方

-0.50 (-0.41%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
120.0026成交張數9.06本益比2.47股價淨值比2.50%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q25.78337.9%13.241.2758.1%12.96%33.36%
2026Q13.29147.4%8.780.7237.0%8.08%24.94%
2025Q42.7489.0%6.820.6032.4%7.24%19.19%
2025Q31.43-3.4%5.530.3123.5%4.35%17.28%
2025Q21.3232.0%5.580.2919.2%4.37%19.29%
2025Q11.33682.4%5.260.2919.4%4.44%19.00%
2024Q41.4579.0%4.100.3218.7%4.88%13.77%
2024Q31.483.460.3323.7%5.25%12.00%
2024Q21.00-16.7%1.650.2214.6%3.77%5.89%
2024Q10.17-61.4%1.850.042.9%0.61%6.93%
2023Q40.81-30.8%2.120.189.9%2.80%7.12%
2023Q3-0.33-163.5%2.48-0.07-4.8%-1.17%8.66%
2023Q21.2096.7%3.330.2616.0%4.31%11.65%
2023Q10.44-44.3%2.740.107.7%1.53%9.88%
2022Q41.1791.8%3.090.2615.3%3.95%10.54%
2022Q30.522.530.118.1%1.78%8.86%
2022Q20.61103.3%1.250.137.4%2.12%4.37%
2022Q10.7964.6%0.940.189.2%2.84%3.38%
2021Q40.6138.6%0.630.136.6%2.16%2.18%
2021Q3-0.76-330.3%0.46-0.17-15.9%-2.70%1.65%
2021Q20.30-26.8%1.550.074.5%1.08%5.45%
2021Q10.48-34.3%1.660.105.5%1.66%5.89%
2020Q40.44-71.4%1.910.104.0%1.54%6.64%
2020Q30.33-68.6%3.010.073.5%1.14%10.83%
2020Q20.41-39.7%3.730.094.7%1.46%13.78%
2020Q10.73-5.2%4.000.167.7%2.60%14.00%
2019Q41.548.5%4.040.3411.1%5.57%14.20%
2019Q31.05-6.3%3.920.238.6%3.98%14.50%
2019Q20.68-34.0%3.990.155.7%2.45%15.35%
2019Q10.77-44.2%4.340.177.4%2.68%14.40%
2018Q41.424.950.3110.2%5.11%17.00%
2018Q31.120.2410.3%4.19%
2018Q21.030.2310.4%3.63%
2018Q11.380.3013.3%4.52%